Carlyle Trims Nature's Bounty Assets: Private Equity Rolls In Supplement Space
This article was originally published in The Rose Sheet
Executive Summary
Carlyle's $2.2bn sale of Nature's Bounty's Holland & Barrett business to a Russian investment fund is the latest sign of the private equity sector's continuing interest in the health and wellness space.
You may also be interested in...
US FTC Collects First ‘Review Hijacking’ Bounty Against Nestle’s Bountiful Supplement Business
FTC proposes order to settle administrative complaint requiring Bountiful Company to pay $600,000 monetary relief for consumers. Order prohibits the Nestle business from using “variation” relationships in e-commerce ads, when positive reviews posted for one product may be confused with a different but similar product.
EU Business News: Reckitt Steps Up Sustainability, Merz Acquires Brooklyn Soap, Holland & Barrett Grows Footprint
Round-up of the latest European consumer health business news: Reckitt joins the RecyClass initiative to make its packaging more sutainable; Germany's Merz extends its Consumer Care offering with Brooklyn Soap acquisition; and retailer Holland & Barrett expands into Greece, Romania and Bulgaria.
KKR Steers Nature's Bounty With Carlyle In Back Seat After Seven-Year Ride
Since acquiring Nature's Bounty in 2010 and taking the publicly traded firm private, Carlyle could have been at the helm longer than executives at the private equity firm intended or expected, exceeding the five-year plan typical for similar investments.